drugset / Trial / NCT04123665

A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride

NCT04123665

Phase 3 Completed 98 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate and compare the gingival health of a test dentifrice (0.454% weight by weight \[w/w\] stannous fluoride) to a negative control dentifrice by comparing modified gingival index, bleeding index and plaque index scores.

Timeline

Start
2013-05-28
Primary completion
2013-12-11
Completion
2013-12-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown 1000 ppm
Subject stannous fluoride Small molecule 0.454 % Oral

Indications